Sera Medical & Linguistic Ltd 07992898 false 2025-04-06 2026-04-05 2026-04-05 The principal activity of the company is that of hospital consultancy Digita Accounts Production Advanced 6.30.9574.0 true 07992898 2025-04-06 2026-04-05 07992898 2026-04-05 07992898 bus:OrdinaryShareClass1 2026-04-05 07992898 core:CurrentFinancialInstruments core:WithinOneYear 2026-04-05 07992898 bus:SmallEntities 2025-04-06 2026-04-05 07992898 bus:AuditExemptWithAccountantsReport 2025-04-06 2026-04-05 07992898 bus:FilletedAccounts 2025-04-06 2026-04-05 07992898 bus:SmallCompaniesRegimeForAccounts 2025-04-06 2026-04-05 07992898 bus:RegisteredOffice 2025-04-06 2026-04-05 07992898 bus:Director1 2025-04-06 2026-04-05 07992898 bus:Director2 2025-04-06 2026-04-05 07992898 bus:Director3 2025-04-06 2026-04-05 07992898 bus:OrdinaryShareClass1 2025-04-06 2026-04-05 07992898 bus:PrivateLimitedCompanyLtd 2025-04-06 2026-04-05 07992898 bus:Agent1 2025-04-06 2026-04-05 07992898 countries:England 2025-04-06 2026-04-05 07992898 2024-04-06 2025-04-05 07992898 2025-04-05 07992898 bus:OrdinaryShareClass1 2025-04-05 07992898 core:CurrentFinancialInstruments core:WithinOneYear 2025-04-05 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 07992898

Sera Medical & Linguistic Ltd

Unaudited Filleted Financial Statements

for the Year Ended 5 April 2026

 

Sera Medical & Linguistic Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

3 to 4

 

Sera Medical & Linguistic Ltd

Company Information

Directors

E Srirangam

S Srirangam

AJ Joseph

Registered office

11 Riverview
The Embankment Business Park
Vale Road
Heaton Mersey
Stockport
SK4 3GN

Accountants

McKellens Limited
Chartered Accountants11 Riverview
The Embankment Business Park
Vale Road
Heaton Mersey
Stockport
SK4 3GN

 

Sera Medical & Linguistic Ltd

(Registration number: 07992898)
Balance Sheet as at 5 April 2026

Note

2026
£

2025
£

Current assets

 

Cash at bank and in hand

 

114,261

90,042

Creditors: Amounts falling due within one year

4

(14,584)

(10,668)

Net assets

 

99,677

79,374

Capital and reserves

 

Called up share capital

5

10

10

Retained earnings

99,667

79,364

Shareholders' funds

 

99,677

79,374

For the financial year ending 5 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 22 July 2026 and signed on its behalf by:
 

.........................................
E Srirangam
Director

.........................................
S Srirangam
Director

 
     
 

Sera Medical & Linguistic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2026

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
11 Riverview
The Embankment Business Park
Vale Road
Heaton Mersey
Stockport
SK4 3GN

These financial statements were authorised for issue by the Board on 22 July 2026.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Sera Medical & Linguistic Ltd

Notes to the Unaudited Financial Statements for the Year Ended 5 April 2026

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2025 - 2).

4

Creditors

Creditors: amounts falling due within one year

2026
£

2025
£

Due within one year

Accruals and deferred income

1,012

1,012

Other creditors

13,572

9,656

14,584

10,668

5

Share capital

Allotted, called up and fully paid shares

2026

2025

No.

£

No.

£

Ordinary shares of £1 each

10

10

10

10